Prismic Pharmaceuticals Acquires Scarista's Exclusive License to Amarin's Omega-3 Patents

News   Feb 08, 2012

 
Prismic Pharmaceuticals Acquires Scarista's Exclusive License to Amarin's Omega-3 Patents
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE